Cardiff Oncology, Inc. CRDF
0.73 USD 0.00 (-0.21%)
Regular-session close
0.73 0.00 +0.54%
After hours · Nov 13, 7:42 PM ET
0.7107 Day range 0.735
0.7261 52-week range 3.21
- YTD
- -74.16%
- 1 year
- -66.23%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.75 +1380.5% upside
Now 0.7261
- Target (low)
- 10.00
- Target (mean)
- 10.75
- Target (high)
- 13.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24667 | -0.29 – -0.20 | -0.21 | -17.5% | 73.00K | -53.2% | 3 |
| Next quarter | -0.25 | -0.31 – -0.21 | -0.22 | -13.6% | 76.00K | -62.9% | 3 |
| Current year | -0.98667 | -1.03 – -0.93 | -0.93 | -6.1% | 592.80K | +21.5% | 3 |
| Next year | -1.02 | -1.32 – -0.83 | -0.98667 | -3.0% | 322.00K | -45.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 6, 2024 | Craig-Hallum | Initiated | — | Buy |
| May 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 6, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 1, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 8, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 9, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 29, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 7, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 13, 2022 | Piper Sandler | Maintained | — | Overweight |
| Aug 29, 2022 | Baird | Maintained | — | Outperform |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 28, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 8, 2021 | Baird | Initiated | — | Outperform |
| Aug 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 22, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 8, 2020 | Piper Sandler | Initiated | — | Overweight |
| Sep 18, 2020 | Maxim Group | Maintained | — | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.